Cancers,
Год журнала:
2025,
Номер
17(5), С. 882 - 882
Опубликована: Март 4, 2025
According
to
data
from
the
World
Health
Organization
(WHO),
lung
cancer
is
becoming
a
global
epidemic.
It
particularly
high
in
list
of
leading
causes
death
not
only
developed
countries,
but
also
worldwide;
furthermore,
it
holds
place
terms
cancer-related
mortality.
Nevertheless,
many
breakthroughs
have
been
made
last
two
decades
regarding
its
management,
with
one
most
prominent
being
implementation
artificial
intelligence
(AI)
various
aspects
disease
management.
We
included
473
papers
this
thorough
review,
which
published
during
5-10
years,
order
describe
these
breakthroughs.
In
screening
programs,
AI
capable
detecting
suspicious
nodules
different
imaging
modalities-such
as
chest
X-rays,
computed
tomography
(CT),
and
positron
emission
(PET)
scans-but
discriminating
between
benign
malignant
well,
success
rates
comparable
or
even
better
than
those
experienced
radiologists.
Furthermore,
seems
be
able
recognize
biomarkers
that
appear
patients
who
may
develop
cancer,
years
before
event.
Moreover,
can
assist
pathologists
cytologists
recognizing
type
tumor,
well
specific
histologic
genetic
markers
play
key
role
treating
disease.
Finally,
treatment
field,
guide
development
personalized
options
for
patients,
possibly
improving
their
prognosis.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(9), С. 4679 - 4679
Опубликована: Апрель 25, 2024
The
chemotactic
cytokine
fractalkine
(FKN,
chemokine
CX3CL1)
has
unique
properties
resulting
from
the
combination
of
chemoattractants
and
adhesion
molecules.
soluble
form
(sFKN)
strongly
attracts
T
cells
monocytes.
membrane-bound
(mFKN)
facilitates
diapedesis
is
responsible
for
cell-to-cell
adhesion,
especially
by
promoting
strong
leukocytes
(monocytes)
to
activated
endothelial
with
subsequent
formation
an
extracellular
matrix
angiogenesis.
FKN
signaling
occurs
via
CX3CR1,
which
only
known
member
CX3C
receptor
subfamily.
Signaling
within
FKN-CX3CR1
axis
plays
important
role
in
many
processes
related
inflammation
immune
response,
often
occur
simultaneously
overlap.
upregulated
hypoxia
and/or
inflammation-induced
inflammatory
release,
it
may
act
locally
as
a
key
angiogenic
factor
highly
hypoxic
tumor
microenvironment.
importance
FKN/CX3CR1
pathway
tumorigenesis
cancer
metastasis
results
its
influence
on
cell
apoptosis,
migration.
This
review
presents
context
angiogenesis
cancer.
mechanisms
determining
pro-
or
anti-tumor
effects
are
presented,
cause
seemingly
contradictory
that
create
confusion
regarding
therapeutic
goals.
Frontiers in Oncology,
Год журнала:
2025,
Номер
15
Опубликована: Фев. 4, 2025
Background
Artificial
intelligence
(AI)
has
emerged
as
a
transformative
tool
in
oncology,
offering
promising
applications
chemotherapy
development,
cancer
diagnosis,
and
predicting
response.
Despite
its
potential,
debates
persist
regarding
the
predictive
accuracy
of
AI
technologies,
particularly
machine
learning
(ML)
deep
(DL).
Objective
This
review
aims
to
explore
role
forecasting
outcomes
related
treatment
response,
synthesizing
current
advancements
identifying
critical
gaps
field.
Methods
A
comprehensive
literature
search
was
conducted
across
PubMed,
Embase,
Web
Science,
Cochrane
databases
up
2023.
Keywords
included
“Artificial
Intelligence
(AI),”
“Machine
Learning
(ML),”
“Deep
(DL)”
combined
with
“chemotherapy
development,”
“cancer
diagnosis,”
treatment.”
Articles
published
within
last
four
years
written
English
were
included.
The
Prediction
Model
Risk
Bias
Assessment
utilized
assess
risk
bias
selected
studies.
Conclusion
underscores
substantial
impact
AI,
including
ML
DL,
on
innovation,
response
for
both
solid
hematological
tumors.
Evidence
from
recent
studies
highlights
AI’s
potential
reduce
cancer-related
mortality
by
optimizing
diagnostic
accuracy,
personalizing
plans,
improving
therapeutic
outcomes.
Future
research
should
focus
addressing
challenges
clinical
implementation,
ethical
considerations,
scalability
enhance
integration
into
oncology
care.
American Journal of Translational Research,
Год журнала:
2024,
Номер
16(2), С. 432 - 445
Опубликована: Янв. 1, 2024
Background:
Human
cell
division
cycle-associated
protein
8
(CDCA8),
a
critical
regulator
of
mitosis,
has
been
identified
as
prospective
prognostic
biomarker
in
several
cancer
types,
including
breast,
colon,
and
lung
cancers.This
study
analyzed
the
diagnostic/prognostic
potential
clinical
implications
CDCA8
across
diverse
cancers.Methods:
Bioinformatics
molecular
experiments.Results:
Analyzing
TCGA
data
via
TIMER2
GEPIA2
databases
revealed
significant
up-regulation
23
types
compared
to
normal
tissues.Prognostically,
elevated
expression
correlated
with
poorer
overall
survival
KIRC,
LUAD,
SKCM,
emphasizing
its
marker.UALCAN
analysis
demonstrated
based
on
variables,
such
stage,
race,
gender,
these
cancers.Epigenetic
exploration
indicated
reduced
promoter
methylation
levels
Kidney
Renal
Clear
Cell
Carcinoma
(KIRC),
Lung
Adenocarcinoma
(LUAD),
Skin
Cutaneous
Melanoma
(SKCM)
tissues
controls.Promoter
mutational
analyses
showcased
hypomethylation
low
mutation
rate
for
cancers.Correlation
positive
associations
between
infiltrating
immune
cells,
particularly
CD8+
CD4+
T
cells.Protein-protein
interaction
(PPI)
network
unveiled
key
interacting
proteins,
while
gene
enrichment
highlighted
their
involvement
crucial
cellular
processes
pathways.Additionally,
CDCA8associated
drugs
through
DrugBank
presented
therapeutic
options
SKCM.In
vitro
validation
using
reverse
transcription-quantitative
polymerase
chain
reaction
(RT-qPCR)
confirmed
LUAD
lines
(A549
H1299)
control
.Conclusion:
This
provides
concise
insights
into
CDCA8's
multifaceted
role
covering
patterns,
diagnostic
relevance,
epigenetic
regulation,
landscape,
infiltration,
implications.
Gels,
Год журнала:
2024,
Номер
10(7), С. 440 - 440
Опубликована: Июль 1, 2024
Cancer
is
a
highly
heterogeneous
disease
and
remains
global
health
challenge
affecting
millions
of
human
lives
worldwide.
Despite
advancements
in
conventional
treatments
like
surgery,
chemotherapy,
immunotherapy,
the
rise
multidrug
resistance,
tumor
recurrence,
their
severe
side
effects
complex
nature
microenvironment
(TME)
necessitates
innovative
therapeutic
approaches.
Recently,
stimulus-responsive
nanomedicines
designed
to
target
TME
characteristics
(e.g.,
pH
alterations,
redox
conditions,
enzyme
secretion)
have
gained
attention
for
potential
enhance
anticancer
efficacy
while
minimizing
adverse
chemotherapeutics/bioactive
compounds.
Among
various
nanocarriers,
hydrogels
are
intriguing
due
high-water
content,
adjustable
mechanical
characteristics,
responsiveness
external
internal
stimuli,
making
them
promising
candidates
cancer
therapy.
These
properties
make
an
ideal
nanocarrier
controlled
drug
release
within
TME.
This
review
comprehensively
surveys
latest
area
therapy,
exploring
stimuli-responsive
mechanisms,
including
biological
pH,
redox),
chemical
enzymes,
glucose),
physical
temperature,
light),
as
well
dual-
or
multi-stimuli
responsiveness.
Furthermore,
this
addresses
current
developments
challenges
treatment.
Our
aim
provide
readers
with
comprehensive
understanding
treatment,
offering
novel
perspectives
on
development
therapy
other
medical
applications.
BMC Medical Informatics and Decision Making,
Год журнала:
2025,
Номер
25(1)
Опубликована: Янв. 31, 2025
Abstract
This
paper
introduces
SkinWiseNet
(SWNet),
a
deep
convolutional
neural
network
designed
for
the
detection
and
automatic
classification
of
potentially
malignant
skin
cancer
conditions.
SWNet
optimizes
feature
extraction
through
multiple
pathways,
emphasizing
width
augmentation
to
enhance
efficiency.
The
proposed
model
addresses
potential
biases
associated
with
conditions,
particularly
in
individuals
darker
tones
or
excessive
hair,
by
incorporating
fusion
assimilate
insights
from
diverse
datasets.
Extensive
experiments
were
conducted
using
publicly
accessible
datasets
evaluate
SWNet’s
effectiveness.This
study
utilized
four
datasets-Mnist-HAM10000,
ISIC2019,
ISIC2020,
Melanoma
Skin
Cancer-comprising
images
categorized
into
benign
classes.
Explainable
Artificial
Intelligence
(XAI)
techniques,
specifically
Grad-CAM,
employed
interpretability
model’s
decisions.
Comparative
analysis
was
performed
three
pre-existing
learning
networks-EfficientNet,
MobileNet,
Darknet.
results
demonstrate
superiority,
achieving
an
accuracy
99.86%
F1
score
99.95%,
underscoring
its
efficacy
gradient
propagation
capture
across
various
levels.
research
highlights
significant
advancing
classification,
providing
robust
tool
accurate
early
diagnosis.
integration
enhances
mitigates
hair
tones.
outcomes
this
contribute
improved
patient
healthcare
practices,
showcasing
exceptional
capabilities
classification.
Electronics,
Год журнала:
2025,
Номер
14(4), С. 710 - 710
Опубликована: Фев. 12, 2025
Accurate
detection
and
diagnosis
of
brain
tumors
at
early
stages
is
significant
for
effective
treatment.
While
numerous
methods
have
been
developed
tumor
classification,
several
rely
on
traditional
techniques,
often
resulting
in
suboptimal
performance.
In
contrast,
AI-based
deep
learning
techniques
shown
promising
results,
consistently
achieving
high
accuracy
across
various
types
while
maintaining
model
interpretability.
Inspired
by
these
advancements,
this
paper
introduces
an
improved
variant
EfficientNet
multi-grade
addressing
the
gap
between
performance
explainability.
Our
approach
extends
capabilities
to
classify
four
types:
glioma,
meningioma,
pituitary
tumor,
non-tumor.
For
enhanced
explainability,
we
incorporate
gradient-weighted
class
activation
mapping
(Grad-CAM)
improve
The
input
MRI
images
undergo
data
augmentation
before
being
passed
through
feature
extraction
phase,
where
underlying
patterns
are
learned.
achieves
average
98.6%,
surpassing
other
state-of-the-art
standard
datasets
a
substantially
reduced
parameter
count.
Furthermore,
explainable
AI
(XAI)
analysis
demonstrates
model’s
ability
focus
relevant
regions,
enhancing
its
This
accurate
interpretable
classification
has
potential
significantly
aid
clinical
decision-making
neuro-oncology.
BMC Bioinformatics,
Год журнала:
2024,
Номер
25(1)
Опубликована: Янв. 9, 2024
Abstract
The
integration
of
biology,
computer
science,
and
statistics
has
given
rise
to
the
interdisciplinary
field
bioinformatics,
which
aims
decode
biological
intricacies.
It
produces
extensive
diverse
features,
presenting
an
enormous
challenge
in
classifying
bioinformatic
problems.
Therefore,
intelligent
bioinformatics
classification
system
must
select
most
relevant
features
enhance
machine
learning
performance.
This
paper
proposes
a
feature
selection
model
based
on
fractal
concept
improve
performance
systems
high-dimensional
proposed
(FFS)
divides
into
blocks,
measures
similarity
between
blocks
using
root
mean
square
error
(RMSE),
determines
importance
low
RMSE.
FFS
is
tested
evaluated
over
ten
datasets.
experiment
results
showed
that
significantly
improved
accuracy.
average
accuracy
rate
was
79%
with
full
algorithms,
while
delivered
promising
94%.